Kateřina Dědečková

Role of [18F]-fluoro-2-deoxy-<scp>d</scp>-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone

Jana Marková, Deniz Kahraman, Carsten Kobe et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 57 citations

Positron Emission Tomography, Lymphoid Neoplasia, Oncologic Imaging +14

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Georgios Ntentas, Kateřina Dědečková, Michal Andrlík et al. · Practical Radiation Oncology · 2019 · 36 citations · Full text

Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes

Jiří Kubeš, Alexandra Haas, Vladimír Vondráček et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 18 citations

Radiation Medicine, Nuclear Medicine, Radiation Therapy +9

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results

Jiří Kubeš, Vladimír Vondráček, Michal Andrlík et al. · Journal of Medical Imaging and Radiation Oncology · 2019 · 16 citations

Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration

Yolanda D. Tseng, Bradford S. Hoppe, Kateřina Dědečková et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 14 citations

Oncology, Pcg Collaboration, Mediastinal Proton Therapy +3